Clinical Trial

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection

Study acronym: PETRUM
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-30
Trial Details
NCT Number NCT07663669
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Conditions Antibody-mediated Rejection in Kidney Transplant
Enrollment 31 participants
Start Date 2026-06
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-29